In a year dominated by onshoring stories, Aragen has seized the advantages of running a biotech business in India.

Livestock vaccine demand surges but requires specialized animal-vaccine manufacturing workflows with distinct production requirements from human vaccines.

The milestone is being celebrated as a “huge moment” for rare disease drug development.

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

Explore the latest news and expert commentary by Fiona Ford, brought to you by the Contributor of BioProcess International.

Explore the latest news and expert commentary by Melissa Nixon, brought to you by the Contributor of BioProcess International ...

According to the public release, Andelyn Biosciences and the Drake Rayden Foundation will work in partnership with Steven ...

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as next-generation technology.

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.

AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for faster life-saving therapies.

The US Food and Drug Administration (FDA) announced the launch of a new framework to expedite therapies for ultra-rare diseases. The program will focus on targeted, individualized treatments for ...

Axplora invests $30 million in lyophilization at Le Mans site, boosting ADC production. Facilities enhance control, reliability, and traceability.